Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 4/2002

01-05-2002

Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden)

Authors: Qin Liu, Joanne Wuu, Mats Lambe, Shu-Feng Hsieh, Anders Ekbom, Chung-Cheng Hsieh

Published in: Cancer Causes & Control | Issue 4/2002

Login to get access
Metadata
Title
Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden)
Authors
Qin Liu
Joanne Wuu
Mats Lambe
Shu-Feng Hsieh
Anders Ekbom
Chung-Cheng Hsieh
Publication date
01-05-2002
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 4/2002
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1015287208222

Other articles of this Issue 4/2002

Cancer Causes & Control 4/2002 Go to the issue

Editorial Commentary

Dual effect of first full term pregnancy on breast cancer risk: empirical evidence and postulated underlying biology

OriginalPaper

Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study

OriginalPaper

Breast self-examination: who teaches it, who is taught, and how often? (United States)

OriginalPaper

Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men

OriginalPaper

Cancer incidence in California flight attendants (United States)

OriginalPaper

Association of correlates of endogenous hormonal exposure with breast cancer risk in 426 families (United States)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits